TEHR vs DrCare247: Which Operating Model Fits?

How do TEHR and DrCare247 compare?

Public vendor information below was reviewed as of October 22, 2026. “Not stated on reviewed pages” means unverified, not absent. Included capabilities still require an agreement defining fees, availability and responsibility.

What is the real decision between these infrastructure platforms?

An established health brand usually arrives with assets it cannot casually discard: an audience, trusted communications, active orders, customer support routines and clinician relationships. The decision is whether a new infrastructure agreement improves those assets without breaking the responsibilities underneath them. Start with your operating model, not a feature checklist assembled from two homepages.

Write down what you want the vendor to own every morning. That might include appointment administration, routing an incomplete intake, responding to a shipment question and reconciling a canceled subscription. Write down separately what remains with your team and what belongs to independent clinicians. This three-way map makes the white-label telehealth model concrete. A proposal that cannot name the owner of an exception is not yet ready for a meaningful price comparison.

When should a brand choose TEHR?

Choose TEHR when the team wants a branded operating platform, coordinated access to independent clinical services and a commercial structure tied to flat subscription and transaction fees. The relevant advantage is fit with your proposed business, not an unsupported claim that another provider cannot offer similar functions. Review the TEHR platform against a real patient journey from first purchase through follow-up.

TEHR was built by operators behind DudeMeds, Peptiders, TellyMeds and FansMeds. That background is useful when discussions reach operational details such as subscription changes and patient transitions. It is not a substitute for contractual scope or evidence from your own acceptance test. Ask TEHR to demonstrate the workflow your staff will actually run, including a customer who needs administrative help after the clinician has made a decision.

When should a brand choose DrCare247?

Consider DrCare247 if its proposed configuration, care partners and service responsibilities match your needs, especially if you want to evaluate an integrated infrastructure model alongside TEHR. Its current platform page explicitly describes customer-supplied or vendor-supplied physicians. That is a useful procurement branch for a group that already employs or contracts with clinicians.

Request two statements of work if you are undecided about retaining your existing clinical relationships. One should assume your clinicians continue. The other should describe the vendor's proposed clinical arrangement. Compare handoffs, training, scheduling ownership and record access rather than simply counting features. If DrCare247's scoped answer better preserves a valuable existing operation, that is a sound reason to select it. A fair comparison should leave room for that outcome.

How should you compare the complete commercial proposal?

Use the same planning assumptions for both quotes: new patient starts, recurring patients, scheduled consultations, asynchronous reviews, support contacts and fulfilled orders. Ask which event triggers each fee. An order, a payment, a completed consultation and a shipped prescription are different events; a headline transaction amount does not explain their relationship.

The TEHR pricing page describes the commercial model, but confirmed dollar amounts remain necessary. Ask both teams to price an ordinary month and an operationally awkward month with cancellations, extra follow-up and failed payments. Keep medication, laboratory, processing and clinical charges visible rather than burying them in a blended total. Revenue share is a distinct contract term; an unpublished rival policy cannot be assumed to be a percentage charge. The winner should be clear after all mandatory costs are included.

What should an existing brand preserve during migration?

Start by separating active clinical work from historical data. A customer waiting on an unreviewed intake has a different transition need from someone with a completed encounter and no upcoming activity. Prepare cohorts for open consultations, outstanding lab results, unshipped orders, subscriptions and historical records. Give each cohort an owner, a destination and a reconciliation check.

Use the patient migration checklist before anyone promises a cutover date. A spreadsheet of customer names is not a verified transfer of the operational state. Require sample exports, attachment handling, identity matching and a decision about overlapping billing windows. Neither this comparison nor a vendor's launch timetable proves an export right, a payment-token transfer or a universal migration duration. Those questions belong in the transition plan, with a fallback if the first test fails.

How do you test the difference between a launch and a ready operation?

Create a rehearsal that begins with a branded entry page and ends with a closed support case. Include an incomplete intake, an ineligible patient, a clinician requesting more information, an appointment moved to another day and a customer canceling renewal. The purpose is to discover where responsibility changes hands and whether the next person receives enough context.

Agree acceptance criteria before the demonstration. For example, every test payment should reconcile to the correct administrative record, and every unresolved question should have a visible owner. These are project requirements you can propose, not claims about either platform's current implementation. Record failures and retest only the affected paths. An attractive dashboard is reassuring; an exception that moves cleanly from one responsible team to the next is stronger evidence of readiness.

What needs separate review for programs and certification?

Treat the requested program catalog as a signed scope, not a collection of category names. Ask for the states, visit modalities, patient eligibility rules and fulfillment arrangements applicable to the first programs you plan to sell. Independent licensed clinicians retain clinical judgment; a brand purchase must never be described as a guaranteed prescription.

Likewise, a certification badge requires a scope question: which entity and domain does it cover, and what must your customer-facing brand complete? Do not assume supplier approval transfers automatically. TEHR's peptide page states the status of selected pending programs: they are not open for prescribing or fulfillment. If peptides are central to the business plan, model a launch without those pending programs rather than treating a future policy announcement as an automatic revenue date.

What should the final selection meeting produce?

Bring a short decision record rather than another round of broad sales questions. It should identify the preferred operating model, the commercial assumptions, the unresolved program questions and the minimum evidence needed to approve a pilot. A missing answer is a task to close, not a reason to invent a negative finding about a vendor.

If you need a wider market view, review DrCare247 alternatives and the turnkey platform buying guide. Then return to the two actual proposals. Choose the vendor whose documented responsibilities and test results fit your organization. If neither can support the first care journey under acceptable terms, narrow the initial program or continue the search. A deliberate small launch is more useful than an expansive contract with unresolved operational ownership.

What else should you know?